Lopes Luciana B, Speretta Fernanda F F, Bentley M Vitória L B
Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Av. do Café, s/n, 14040-930, Ribeirão Preto, SP, Brazil.
Eur J Pharm Sci. 2007 Nov;32(3):209-15. doi: 10.1016/j.ejps.2007.07.006. Epub 2007 Aug 11.
Application of vitamin K (vitK) to the skin has been used for suppression of pigmentation and resolution of bruising. However, there is no report concerning the extent of its penetration in the skin. In this study, we investigated the in vitro skin penetration and transdermal delivery of vitK, and whether these parameters may be enhanced by lipid-based drug delivery systems. The lipid formulation used in this study contains monoolein (MO), which is structured as a liquid crystalline phase, named hexagonal phase. The skin penetration of vitK was assessed in vitro using porcine ear skin mounted in a Franz diffusion cell. VitK (2.5%, w/w) was incorporated in either of three formulations: liquid vaseline, MO-based hexagonal phase gel (MO-vitK-water at 77.5/2.5/20, w/w/w) and MO-based nanodispersion of hexagonal phase (MO-vitK-poloxamer-water at 15/2.5/0.9/81.6, w/w/w/w). When vaseline was used, vitK was delivered mainly to the stratum corneum (SC): 9.50+/-0.97 microg/cm(2) of vitK was delivered to the SC at 12 h post-application, whereas 4.90 +/- 1.28 microg/cm(2) of vitK was delivered to the epidermis (E)+dermis (D) at the same time point. The hexagonal phase gel and the nanodispersion delivered approximately 2 times more vitK to the SC and 2.0-3.7 times more vitK to the [E+D] than the vaseline solution. The nanodispersion (but not the gel) also increased the transdermal delivery of vitK at 9 h ( approximately 3-fold increase). These results demonstrate that the topical delivery of vitK incorporated in a lipophilic vehicle is small, but it may be enhanced by MO-based systems, which might be useful to increase the effectiveness of topical vitK therapy.
维生素K(vitK)应用于皮肤已被用于抑制色素沉着和消除瘀伤。然而,尚无关于其在皮肤中渗透程度的报道。在本研究中,我们研究了vitK的体外皮肤渗透和透皮递送情况,以及基于脂质的药物递送系统是否可以提高这些参数。本研究中使用的脂质制剂含有单油酸甘油酯(MO),其结构为液晶相,称为六方相。使用安装在Franz扩散池中猪耳皮肤体外评估vitK的皮肤渗透。将vitK(2.5%,w/w)掺入三种制剂中的一种:液体凡士林、基于MO的六方相凝胶(MO-vitK-水,比例为77.5/2.5/20,w/w/w)和基于MO的六方相纳米分散体(MO-vitK-泊洛沙姆-水,比例为15/2.5/0.9/81.6,w/w/w/w)。当使用凡士林时,vitK主要递送至角质层(SC):给药后12小时,9.50±0.97μg/cm²的vitK递送至SC,而在同一时间点,4.90±1.28μg/cm²的vitK递送至表皮(E)+真皮(D)。六方相凝胶和纳米分散体递送至SC的vitK比凡士林溶液多约2倍,递送至[E+D]的vitK多2.0 - 3.7倍。纳米分散体(而非凝胶)在9小时时也增加了vitK的透皮递送(增加约3倍)。这些结果表明,掺入亲脂性载体中的vitK局部递送量较小,但基于MO的系统可能会增强其递送,这可能有助于提高局部vitK治疗的有效性。